Nationwide Children's Hospital logo

Nationwide Children's Hospital

North America, Ohio, United States, Columbus

Description

Nationwide Children’s, we are creating the future of pediatric health care. We consider every detail. Every decision. Every aspect

Investor Profile

Nationwide Children's Hospital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nationwide Children's Hospital frequently co-invest with?

UNC Health Care
North America, North Carolina, United States, Chapel Hill
Co-Investments: 1
Rev1 Ventures
North America, Ohio, United States, Columbus
Co-Investments: 2
JobsOhio
North America, Ohio, United States, Columbus
Co-Investments: 1
University Hospitals
North America, Ohio, United States, Cleveland
Co-Investments: 1
LCMC Health
North America, Louisiana, United States, New Orleans
Co-Investments: 1
Co-Investments: 1
Ohio Innovation Fund
North America, Ohio, United States, Columbus
Co-Investments: 1
Froedtert Health
North America, Wisconsin, United States, Milwaukee
Co-Investments: 1
1776 Ventures
North America, District of Columbia, United States, Washington
Co-Investments: 1
Cincinnati Children’s
North America, Ohio, United States, Cincinnati
Co-Investments: 1

What are some of recent deals done by Nationwide Children's Hospital?

Clarametyx Biosciences

Columbus, Ohio, United States

Clarametyx Biosciences is a late preclinical stage biotechnology company.

BiotechnologyHealth CareMedicalPharmaceutical
Series AJan 5, 2024
Amount Raised: $33,000,000
STAQ Pharma

Denver, Colorado, United States

STAQ Pharma offers safety, transparency, availability, and quality to compounded medications.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series CMar 2, 2022